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Computer-based prediction of protein druggability is an
essential task in the drug development process. Early
identification of disease modifying targets that can be
modulated by low-molecular weight compounds can
help to speed up and reduce costs in drug discovery.
Recently, first methods have been presented performing
a druggability estimation solely based on the 3D struc-
ture of the protein [1-3]. The essential first step for
such methods is the identification of the active site. A
multitude of methods exist for automated active site
prediction [4-6]. However, most methods developed for
automated docking procedures do not explicitly focus
on the definition of the boundary of the active site.
Since druggability estimates are based on structural
descriptors of the active site, a precise description of the
active site boundaries is vital for correct predictions.
In this work, we present a method to predict protein
binding pockets and split them into subpockets such
that small molecules are mostly contained within one
sub-pocket. The method is based on a novel strategy to
geometrically detect narrow regions in pockets. For
druggability predictions, such pocket descriptions result
in more meaningful structural descriptors like active site
surface or volume. Moreover, if several structures from
o n ep r o t e i na r ek n o w n ,s u b - p o c k e t sc a ng i v eh i n t s
about protein flexibility and induced fit conformational
changes.
Our method was evaluated on 718 proteins from the
PDBbind [7] data set, as well as 5419 proteins from the
scPDB [8] data set. Binding pockets are correctly pre-
dicted in 94% and 93% of the datasets. 38%, respectively
45% of the proteins from the two datasets contain
pockets which can be divided into more than one
sub-pocket. In all cases one sub-pocket completely
covers the co-crystallized ligand. Besides the classical
overlap-measure of ligand versus predicted active site,
we additionally considered the pocket coverage by the
co-crystallized ligand. We found that the number of test
cases with more than 30% pocket coverage rises from
30% to 74% (PDBbind) and from 28% to 63% (scPDB),
respectively, when considering sub-pockets.
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